Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis in Mongolia-Reference-Cited by-同舟云学术

Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis in Mongolia

Published:2020-06-23 Issue:7 Volume:64 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Narmandakh Erdenegerel¹,Tumenbayar Oyuntuya¹,Borolzoi Tsetsegtuya¹,Erkhembayar Baasansuren¹,Boldoo Tsolmon¹,Dambaa Naranzul¹,Burneebaatar Buyankhishig¹,Nymadawa Naranbat²,Mitarai Satoshi³,Jav Sarantuya⁴,Chiang Chen-Yuan⁵⁶⁷

Affiliation:

1. National Center for Communicable Diseases, Ulaanbaatar, Mongolia

2. Mongolian Anti-Tuberculosis Coalition, Ulaanbaatar, Mongolia

3. Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan

4. Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia

5. International Union against Tuberculosis and Lung Diseases, Paris, France

6. Division of Pulmonary Medicine, Department of Internal Medicine, Wanfang Hospital, Taipei Medical University, Taipei, Taiwan

7. Division of Pulmonary Medicine, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan

Abstract

Globally, mutations in the katG gene account for the majority of isoniazid-resistant strains of Mycobacterium tuberculosis . Buyankhishig et al. analyzed a limited number of Mycobacterium tuberculosis strains in Mongolia and found that isoniazid resistance was mainly attributable to inhA mutations (B. Buyankhishig, T. Oyuntuya, B. Tserelmaa, J. Sarantuya, et al., Int J Mycobacteriol 1:40–44, 2012, https://doi.org/10.1016/j.ijmyco.2012.01.007 ).

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00537-20

Reference25 articles.

1. World Health Organization. 2018. Global tuberculosis report 2018: document WHO/CDS/TB/2018.20, p 1–231. World Health Organization, Geneva, Switzerland.

2. Isoniazid-resistant tuberculosis: a cause for concern?

3. Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance

4. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and Optimization of Bovine Serum Albumin Nanoparticles Immobilized with Antituberculosis Drugs;EURASIAN JOURNAL OF CHEMISTRY;2024-02-23

2. Mycobacterial β-carbonic anhydrases: Molecular biology, role in the pathogenesis of tuberculosis and inhibition studies;The Enzymes;2024

3. Evaluating the Sensitivity of Different Molecular Techniques for Detecting Mycobacterium tuberculosis Complex in Patients with Pulmonary Infection;Polish Journal of Microbiology;2023-12-01

4. Isoniazid-Resistant Tuberculosis - A Series of Clinical Cases;Internal Medicine;2023-12-01

5. Molecular characterization of genetic mutations with fitness loss in pulmonary tuberculosis patients associated with HIV co-infection in Northwest Amhara, Ethiopia;SAGE Open Medicine;2023-01